Last reviewed · How we verify
NCT03370796
Group Reminiscence Therapy for Elderly People With Cognitive Decline in Institutional Context
NA trial testing Reminiscence Therapy Program in Cognitive Decline in 50 participants. Status unknown.
31 July 2018
Quick facts
| Lead sponsor | Escola Superior de Enfermagem de Coimbra |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 September 2017 |
| Primary completion | 31 July 2018 |
| Estimated completion | 31 July 2018 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Reminiscence Therapy Program
Conditions studied
- Cognitive Decline — all drugs for Cognitive Decline →
- Dementia — all drugs for Dementia →
- Cognitive Impairment — all drugs for Cognitive Impairment →
Sponsor
Escola Superior de Enfermagem de Coimbra
Who can join
65 and older, any sex, with Cognitive Decline or Dementia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The project presented here respond to this emerging need by implementing a Reminiscence Therapy program dedicated to elderly people in an institutional context. This will be a multicenter, randomized controlled study in which the participants' allocation will be made without their knowledge. Before the randomization process, the screening evaluation will be done, which will allow to verify the presence of the inclusion and exclusion criteria. The target population will be people age 65 or above years who present cognitive decline. After the randomization process, participants will be allocated randomly in the experimental group where the reminiscence program (composed by a main strand and maintenance strand) or in the usual institutional care group. The evaluation of the participants will be carried out individually and will take place in four different moments.This study will be conducted in RSE in the central region of Portugal.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03370796
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognitive Decline
Currently open trials in the same condition.
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT07394504 — Effects of Turning Based Dual Task Training on Balance and Mild Cognitive Impairment in Diabetic Peripheral Neuropathy · NA · recruiting
- NCT07127965 — Exercise Adherence and Cognitive Decline: Phase 2 · NA · recruiting
- NCT07151365 — Plant-based Diets and Healthy Aging · recruiting
- NCT07399418 — TRIAD - Tracking Risk in Integrated Alzheimer's Diagnostics. · recruiting
Other Escola Superior de Enfermagem de Coimbra trials
Trials by the same sponsor.
- NCT05197166 — Baropodometric Assessment of the Podiatric Profile of Nursing Students in Clinical Settings · completed
- NCT05966207 — Individual Intervention of Cognitive Stimulation · NA · completed
- NCT04085042 — Impact of a Multimodal Intervention on Peripheral Venous Catheterization of Cancer Patients · NA · completed
- NCT03563703 — Transfer of Technological Innovations to Nursing Practice: A Contribution to the Prevention of Infections · NA · completed
- NCT03390478 — Promoting Independent Living in Frail Older Adults by Improving Cognition and Gait Ability and Using Assistive Products · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03370796 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Escola Superior de Enfermagem de Coimbra
- Last refreshed: 11 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03370796.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing